ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Toviaz, Retardtabletten 4 mg - 84 Tablette(n)
58743003 Pfizer AG
Toviaz, Retardtabletten 4 mg18.12.2008
Original18.12.2008
Fesoterodine (G04BD11) 
WHO-DDD 
05.02.84 Tablette(n)
05.02. 
B  
Yes 
IPCI
57.92No
    
10 %79.10
7680587430037Synthetika
4059384 
Composition
fesoterodini fumaras 4.0 mg corresp. fesoterodinum 3.1 mg, xylitolum, lactosum monohydricum 91.1 mg, cellulosum microcristallinum, hypromellosum, glyceroli dibehenas, talcum, poly(alcohol vinylicus), macrogolum 3350, talcum, lecithinum ex soja, E 171, E 132, pro compresso.
Packungsbestandteile
Active AgentDose
Fesoterodini Fumaras4 mg correspond Fesoterodinum 3.1 mg
BAG: Active AgentDose
Fesoterodini Fumaras4 mg
Inactive agentsDoseadditional_information
Cellulosum Microcristallinum  
E 132 color.
E 171 color.
Glyceroli Dibehenas  
Hypromellosum  
Lactose Monohydrate91.1 mg 
Lecithinum ex Soja  
Macrogol3350  
Poly(Alcohol Vinylicus)  
Pro Compresso  
Talcum  
Xylitol  
 
Source
Data was imported : 06.12.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home